Board
John Eales is a former Australian Rugby Union player who led the Wallabies from 1996 to his retirement in 2001. Since then, John has held various non-Executive Director positions in listed ASX businesses and unlisted businesses which he has invested in. His interest and investment in DMC has been further enhanced through his family’s experience with anaphylaxis.
Professor Fraser is an intensive care specialist, researcher, clinician scientist, innovator and disruptor. His scientific endeavours have highlighted to him the potential of medical technologies in the heart and lung arena when developed symbiotically with world class clinicians, researchers, developers - with the patient at the heart of these innovation.
Dr Glen Richards is a veterinary surgeon and the founder and former CEO of Greencross Limited, Australia’s largest pet care company. Glen spent 10 years building a multi-million dollar integrated pet care empire, which now operates more than 200 veterinary hospitals and 300 pet care retail stores in Australia and Animates in New Zealand.
Kimberly Hill is an experienced MedTech executive with over 20 years in commercial, technical, and operational leadership across the U.S., Australia, and APAC. A dual American and Australian citizen, she brings a global lens to go-to-market strategy and execution, emphasizing strategic market entry, scalable operational planning, and tailored customer engagement to successfully commercialize innovative healthcare technologies.
Greg Spurgin graduated from the University of Queensland in 1991 with degrees in both Physical therapy and Human Movement Studies. One year later, Greg founded the Allsports Physical Therapy group with six outpatient clinics within Brisbane and Australia.
Professor Arthur Slutsky is an intensive care specialist, researcher, clinician scientist, engineer, innovator and entrepreneur.
LEADERSHIP TEAM
Professor Fraser is an intensive care specialist, researcher, clinician scientist, innovator and disruptor. His scientific endeavours have highlighted to him the potential of medical technologies in the heart and lung arena when developed symbiotically with world class clinicians, researchers, developers - with the patient at the heart of these innovation.
Sonia Barber is an internationally recognised lawyer. She has practiced in Australia and the Middle East for almost 20 years, advising clients on all legal facets of their operations. Sonia holds director or management advisory positions with a number of enterprises.
John brings over 30 years’ experience in commercial, business and strategic advisory, governance, corporate, investment and project skills to De Motu Cordis. He has 23 years’ corporate banking experience, occupying senior banking roles with both ANZ and Suncorp.